Masashi Abe

Masashi Abe is an accomplished professional in the pharmaceutical and regenerative medicine sectors, currently serving as the Primary Focus Modality Lead for Blindness and Beyond and Director of Strategy in Research Strategy & Communications at Astellas Pharma since April 2023. Prior to this role, Masashi Abe held several key positions at Astellas Institute for Regenerative Medicine from May 2016 to March 2023, including Director of Research, Associate Director of Ocular Programs, and Senior Scientist. Earlier experience includes a role as Research Scientist at Astellas Pharma from September 2013 to April 2016. Masashi Abe earned a Doctor of Philosophy (Ph.D.) in Molecular Biology, Aging from the University of Pennsylvania between 2008 and 2013 and completed a degree at The University of Tokyo from 2002 to 2008.